Back to search

Netherlands· NL-d92077915c62

Posiforlid 20 mg/g, oogzalf

A bibrocathol product containing bibrocathol, registered in Netherlands by URSAPHARM Benelux B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC S01AX05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPosiforlid 20 mg/g, oogzalfATCS01AX05REGISTER NO.NL-d92077915c62PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Bibrocathol is registered in 11 of 19 countries.

Countries holding a registration under ATC S01AX05 (bibrocathol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Bibrocathol · ATC S01AX05

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BIBROCATHOL
Manufacturer
URSAPHARM Benelux B.V.
Country
Netherlands (NL)
ATC code
S01AX05
ATC class
Bibrocathol
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    127073

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bibrocathol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bibrocathol products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Bibrocathol-Pos
  • Belgium · Bibrocathol-Pos
  • Czechia · Posiforlid
  • Germany · Posiforlid, Posiformin
  • Denmark · Posiforlid
  • Spain · Posiforlid
  • Finland · Posiforlid
  • Ireland · Posiforlid
  • Iceland · Posiforlid,
  • Italy · Posiforlid
  • Luxembourg · Bibrocathol-Pos
  • Malta · Posiforlid
  • Norway · Posiforlid
  • Poland · Bibrocathol Pos
  • Portugal · Bibrocatol Ursapharm
  • Sweden · Noviform
  • Slovakia · Posiforlid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5d2e25e-4053-47d1-8079-e564cff6ab33
GET /v1/drugs/d5d2e25e-4053-47d1-8079-e564cff6ab33?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogzalf",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127073_smpc.pdf",
  "strength": null,
  "atc_label": "Bibrocathol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127073",
  "excipients": [
    "PARAFFINE, VLOEIBAAR (E905)",
    "VASELINE, WIT",
    "WOLVET"
  ],
  "substances": [
    "BIBROCATHOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127073.pdf",
  "authorised_at": "2022/01/28",
  "procedure_number": "DE/H/6789/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127073",
  "additional_monitoring": "N"
}

See everything about bibrocathol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.